Back to companies

Emergent BioSolutions Inc: Premium Databases

Emergent BioSolutions Inc Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Emergent BioSolutions Inc Insights data

Headline Published Journalists
Showing 3 of 20+ results. Subscribe to unlock more.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 14 Jul 2022 Lorem
NIH’s hIVIG trial in hospitalized COVID-19 patients close to meeting recruitment target; outpatient study planned for start in next few months, sources say 29 Jan 2021 Manasi Vaidya
hIVIG trials to hurt from convalescent plasma use in COVID-19; manufacturing limitations to likely present hurdles, experts say 28 Oct 2020 Manasi Vaidya
hIVIG efforts likely to outdo convalescent plasma in COVID-19, but efficacy magnitude unclear with background use of Gilead’s Veklury, experts say 27 Oct 2020 Manasi Vaidya
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer